Controversies Challenges Consensus
}

About honorapamplin

This author has not yet filled in any details.
So far honorapamplin has created 88 blog entries.

CX 2024: Over 20 Hours of CX Education On-Demand

2024-06-27T11:10:23+01:00

 

The 46th Charing Cross International Symposium, 23 – 25 April 2024 featured world-class education presented by key experts from the global vascular and endovascular community. All educational content including exclusive abstract presentations is available to view on-demand. Aortic Highlights:

  • Most Viewed Session: Aortic Techniques & Technologies: Dissection
  • Debate: Best medical treatment […]
CX 2024: Over 20 Hours of CX Education On-Demand2024-06-27T11:10:23+01:00

CX 2024: Competition Winners and Top Performers

2024-05-07T11:34:55+01:00

Community and collaboration are at the heart of the Charing Cross Symposium. We want to recognise our top contributors and delegates who competed and showed their expertise in competitions, who are all vital members of the CX community!

Top Scoring Abstract Presentations: 

Senior Clinical Abstract Winner:

  • Rockwood Frailty Scale score above 5 is associated with a six-fold […]
CX 2024: Competition Winners and Top Performers2024-05-07T11:34:55+01:00

CX 2024: Brand new data on cyanoacrylate glue, bioprosthetic valves and intensive pulmonary embolism treatments

2024-03-26T14:31:01+00:00

Manj Gohel (Cambridge, UK) and member of the Venous Executive Board parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM programme, SAVVE trial and SYNCHRONOUS trial, which will all present results for the very first time to an international audience at the Charing Cross International Symposium 2024 […]

CX 2024: Brand new data on cyanoacrylate glue, bioprosthetic valves and intensive pulmonary embolism treatments2024-03-26T14:31:01+00:00

CX 2024: Get a ringside seat for the big BASIL-3 data reveal

2024-03-14T11:40:59+00:00

No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence

Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results of this long-awaited, only fully publicly funded randomised controlled trial (RCT) at CX 2024 (23–25 April, London, UK).

CX 2024: Get a ringside seat for the big BASIL-3 data reveal2024-03-14T11:40:59+00:00

45 Year Legacy of CX Vascular Education Continues

2023-10-10T12:59:22+01:00

Three newly appointed Charing Cross International Symposium (CX) Co-chairs will ensure Roger Greenhalgh’s inspiring legacy of vascular education continues at CX 2024 with the 46th CX Symposium. Dittmar Böckler (Heidelberg, Germany), Andrew Holden (Auckland, New Zealand) and Erin Murphy (Charlotte, United States) speak about CX founder Roger Greenhalgh’s lasting legacy and the honour of leading […]

45 Year Legacy of CX Vascular Education Continues2023-10-10T12:59:22+01:00

CX 2024: Chairman’s Address

2023-09-21T14:39:04+01:00
Filmed in the newly completed CX Studio, CX Chair Professor Roger Greenhalgh (London, UK), outlines the plans for CX 2024. Now in its 46th year, the Charing Cross Symposium continues to champion world-class education, innovation and evidence and opens its doors to the global vascular and endovascular community.

Don’t miss […]

CX 2024: Chairman’s Address2023-09-21T14:39:04+01:00

CX 2024: The Delegate Perspective

2023-09-06T11:03:17+01:00

What to Expect In-Person @ CX 2024

I attend CX to network with international colleagues in the field of vascular surgery. The best part of CX was seeing my colleagues again in-person after the pandemic years.

The best thing for me about Charing Cross was the opportunity to deal hands-on with new technologies.

The IT […]

CX 2024: The Delegate Perspective2023-09-06T11:03:17+01:00

How to Write a Successful Abstract

2023-10-10T16:40:58+01:00

Abstract submissions for CX 2024 are now open! We are inviting senior and trainee clinicians working in the vascular and endovascular field to submit abstracts to be considered for in-person presentations and electronic posters in the CX 2024 Vascular & Endovascular Controversies Update, in-person and virtual from London, UK, 23-25 April 2024 (Tuesday to […]

How to Write a Successful Abstract2023-10-10T16:40:58+01:00

CX 2023 Abstract Winners

2023-10-10T16:53:18+01:00

The CX Executive and Abstract Boards would like to congratulate the senior and trainee clinicians who presented their abstracts at the Charing Cross Symposium 2023. In total over 50 abstracts were presented across the main programme and additional activities coving abdominal, peripheral, aortic arch, venous & lymphatic, vascular trauma, acute stroke and vascular access topics.

The […]

CX 2023 Abstract Winners2023-10-10T16:53:18+01:00

CX 2023 Abstract Poster Winners

2023-05-09T14:00:12+01:00

CX 2023 received over 350 abstract submissions and saw 50+ live presentations during the event. The presented abstracts were scored by an expert panel of moderators. The selected abstract sessions featured poster presentations from researchers from across the globe.

Abstract Poster Winner: Ali Kordzadeh

The top scoring abstract poster […]

CX 2023 Abstract Poster Winners2023-05-09T14:00:12+01:00

CX 2023 Hurting Leg Competition Winners

2023-05-05T15:13:46+01:00

We are happy to announce that the winning infomercial and infographics for the Hurting Leg Competition have been chosen!

The winners were selected via online public vote during the Rouleaux Club’s programme session on Thursday 27 April 2023. To relive this fantastic moment, you can view the session in full on-demand (you must be registered for […]

CX 2023 Hurting Leg Competition Winners2023-05-05T15:13:46+01:00

CX 2023: Get the most from your Charing Cross experience!

2023-04-18T11:41:20+01:00

Watch this video to discover how to get the most from your CX experience – for both in-person and virtual delegates.

This video demonstrates how to use the mycx app / mycxonline web platform.

Learn how to;

– Access the full event programme

– Watch live content

– Participate in live discussion

– Create your own daily agenda

– Watch […]

CX 2023: Get the most from your Charing Cross experience!2023-04-18T11:41:20+01:00

CX 2023: 45 Years of Looking Forward

2023-04-14T10:56:48+01:00

 

CX 2023: 45 Years of Looking Forward

  • 1978: Founded in 1978, the Charing Cross Symposium has gone on to become the leading global vascular symposium.

First held at the Drew Lecture Theatre of the Charing cross Hospital Medical School, CX provides first-class Education, Innovation and Evidence presented by world-leading experts.

  • 1987: Dr. Michael DeBakey, vascular pioneer, […]
CX 2023: 45 Years of Looking Forward2023-04-14T10:56:48+01:00

CX 2023: Reaching a Peripheral Consensus with an Expert Faculty

2023-04-12T12:24:11+01:00

We spoke with Marianne Brodmann (Graz, Austria) who kindly shared her highlights of the upcoming Charing Cross 2023 programme. Dr. Brodmann also speaks on a number of interesting topics including; the value of a transradial approach for vascular disease interventions, predictors of drug-coated balloon efficacy in femoropopliteal intervention, the BEST CLI trial and the importance […]

CX 2023: Reaching a Peripheral Consensus with an Expert Faculty2023-04-12T12:24:11+01:00

CX 2023: Reaching a Multidisciplinary Consensus

2023-04-07T12:55:06+01:00

 

In conversation with CX Chairman Professor Roger Greenhalgh, aortic expert Alexander Zimmerman (Zurich, Switzerland) discusses the upcoming Aortic course (Wednesday, 26 April), the importance of continuous education for the practicing surgeon and, a multidisciplinary approach to treating and managing the aorta.

A multidisciplinary approach to aortic aneurysm repair 

Professor Zimmerman focuses on the importance of an taking interdisciplinary approach to […]

CX 2023: Reaching a Multidisciplinary Consensus2023-04-07T12:55:06+01:00

CX 2023: Innovation and Audience Interaction

2023-04-03T16:54:53+01:00

Professor Andrew Holden (Auckland, New Zealand) is really excited about the 18 podium first presentations showcasing new data at CX 2023 and uniquely, the interaction between a world-class faculty and expert audience.

Register now to attend CX 2023! Take a look at the upcoming podium first highlights below.


CX 2023 – PODIUM FIRST:
CX 2023: Innovation and Audience Interaction2023-04-03T16:54:53+01:00

CX 2023: Challenging the Vascular Status Quo

2023-03-31T15:19:32+01:00

 

In this conversation between CX chairman Roger Greenhalgh and Professor of Vascular Surgery, Maarit Venermo (Helsinki, Finland), we discuss the importance of challenging the status quo in vascular and endovascular surgery.

Professor Venermo discusses challenging the status quo in superficial femoral artery management, non-invasive methods and her thoughts on aneurysms in the carotid artery “I’ve heard some […]

CX 2023: Challenging the Vascular Status Quo2023-03-31T15:19:32+01:00

CX 2023: Reaching Venous Consensus with a World-Class Faculty

2023-03-21T15:55:58+00:00

“I think the Charing Cross programme has worked very hard to make a comprehensive and up-to-date consensus on what we have available to us now, what we know now and where we are going.”

This week we sat down with Executive Board member and vascular surgeon Erin Murphy (Charlotte, United States) to talk […]

CX 2023: Reaching Venous Consensus with a World-Class Faculty2023-03-21T15:55:58+00:00

CX 2023: Aortic Techniques & Technologies Highlights

2023-03-06T16:46:42+00:00

Start planning your CX 2023 itinerary today! We sat down with CX Executive Board member, Tilo Kölbel (Hamburg, Germany), to discuss the upcoming presentations in the Aortic techniques & technologies sessions. Register for the CX 2023 Consensus Update today!

Tilo Kölbel’s Highlights:

  • Edited Case: Guo’s aortic arch reconstruction: A prospective, multiple center study about the safety and efficacy of […]
CX 2023: Aortic Techniques & Technologies Highlights2023-03-06T16:46:42+00:00

CX 2023: Andrew Bradbury discusses BASIL-2 trial

2023-03-01T12:20:34+00:00

“I am really looking forward to seeing everyone at CX 2023 and it is going to be a great meeting. It is a pleasure and a privilege for us to be part of it and have the opportunity to present our trial data for the first time.”

Data and discussion on revascularisation treatment […]

CX 2023: Andrew Bradbury discusses BASIL-2 trial2023-03-01T12:20:34+00:00

CX 2023: Rouleaux Club’s Hurting Leg Competition

2023-02-06T10:23:39+00:00

The Rouleaux Club, in association with Charing Cross International Symposium 2023 and BIBA Medical Ltd, are holding a competition to create an infographic and/or infomercial intended to educate members of the public in Chronic Limb Threatening Ischaemia (CLTI) in a competition entitled “The Hurting Leg”. The competition will hopefully “encourage patients to present early to their GPs with […]

CX 2023: Rouleaux Club’s Hurting Leg Competition2023-02-06T10:23:39+00:00

CX 2023: Inspiring the Next Generation of Vascular Specialists with Sophie Renton

2023-02-03T16:35:46+00:00

“It is absolutely key that we enthuse the young and that we show them what we can do in order to be interested in joining our professions.”

CX is offering more opportunities and benefits for trainees, fellows, early career surgeons and physicians than ever before. This week we sat down with Sophie Renton (London, UK), a consultant […]

CX 2023: Inspiring the Next Generation of Vascular Specialists with Sophie Renton2023-02-03T16:35:46+00:00

CX 2023: Reaching Peripheral Arterial Consensus with a World-Class Faculty

2023-01-04T11:18:41+00:00

Endovascular and Interventional Radiology Consultant Bella Huasen (Preston, United Kingdom) stopped by the CX studio to chat about the upcoming Charing Cross Symposium in April 2023.

Like all of us, she is looking forward to CX – to networking, debating and reaching consensus on peripheral arterial topics. We will be welcoming over 2,500 delegates, virtually and […]

CX 2023: Reaching Peripheral Arterial Consensus with a World-Class Faculty2023-01-04T11:18:41+00:00

The Top Cardiovascular News Stories of 2022!

2023-01-02T03:57:22+00:00

What a year! We are taking a look back at the most viewed news stories. Check out these top stories and videos and make sure you haven’t missed any of 2022’s most-viewed news!

Remember – you can still claim up to 24 reciprocal EU/US CME credits for viewing CX 2022 and CX […]

The Top Cardiovascular News Stories of 2022!2023-01-02T03:57:22+00:00

What to Expect at Charing Cross 2023

2023-01-02T04:01:36+00:00

As the year comes to a close, we are looking forward to 2023 and what is in store for CX attendees in April! There are so many fantastic reasons to attend CX in-person or online, see you in 2023!

What to Expect at CX 2023:

  • First-time data releases
  • Debates
  • Masterclasses
  • Workshops
  • CME points
  • Exclusive networking opportunities
  • […]

What to Expect at Charing Cross 20232023-01-02T04:01:36+00:00

CX 2023: Reaching Renal Interventional and Vascular Access Consensus with a World-Class Faculty

2022-12-09T17:21:06+00:00

This year, we aim to reach consensus on renal interventional and vascular access issues. With the help of a world-class faculty, we will be leading a one day vascular access masterclass and workshop in London, which is the largest in Europe. We spoke with CX executive board members, Nick Inston (Birmingham, UK) and Kate Steiner […]

CX 2023: Reaching Renal Interventional and Vascular Access Consensus with a World-Class Faculty2022-12-09T17:21:06+00:00

CX 2023: Reaching Aortic Consensus with a World-Class Faculty!

2022-12-01T17:02:54+00:00

This year we expect over 2,500 in-person and 1,000 virtual participating vascular specialists to join us. In previous years we have hosted over 6,000 registrants virtually from over 120 countries due to the COVID-19 pandemic and are very excited to be back in London 25-27 April 2023. To make CX as accessible as possible, registrants will also have […]

CX 2023: Reaching Aortic Consensus with a World-Class Faculty!2022-12-01T17:02:54+00:00

CX 2023: Reaching Venous and Lymphatic Consensus with a World-Class Faculty

2022-12-15T12:26:15+00:00

CX 2023 is seeking to reach venous and lymphatic consensus on topics related to the superficial, deep and pelvic veins as well as venous ulcers and lymphatics. Reaching consensus this year will round out our three-year cycle of controversies, challenges and consensus. Topics will be addressed by the world-class CX faculty alongside […]

CX 2023: Reaching Venous and Lymphatic Consensus with a World-Class Faculty2022-12-15T12:26:15+00:00

CX 2021: Venous and Lymphatic Highlights

2021-04-29T20:09:24+01:00

CX 2021 has finished but that does not mean you have missed your opportunity to view all the high-quality content that was on display. All our sessions, from both Livestream 1 and Livestream 2, are available on-demand on our dedicated CX 2021 channel.

To get access to the entire content from […]

CX 2021: Venous and Lymphatic Highlights2021-04-29T20:09:24+01:00

CX 2021: Abdominal Aortic Highlights

2021-04-29T20:06:21+01:00

CX 2021 has finished but that does not mean you have missed your opportunity to view all the high-quality content that was on display. All our sessions, from both Livestream 1 and Livestream 2, are available on-demand on our dedicated CX 2021 channel.

To get access to the entire content from […]

CX 2021: Abdominal Aortic Highlights2021-04-29T20:06:21+01:00

Vascular Trauma Controversies at CX 2021

2021-04-01T18:09:16+01:00

Christopher Aylwin (UK) talks about resuscitative endovascular balloon occlusion of the aorta (REBOA), which he notes will likely be the biggest controversial topic in this year’s Vascular […]

Vascular Trauma Controversies at CX 20212021-04-01T18:09:16+01:00

CX 2021: Vascular Access programme targets impact of high-flow arteriovenous fistulas

2021-03-26T14:09:26+00:00

International practice differences exist in cannulation and dialysis provision with some approaches aiming for fistulas to suit the logistics of dialysis, rather than best long-term outcomes for the fistula and the patient

The CX 2021 Vascular Access Controversies Programme is designed to showcase the latest advances and disputes […]

CX 2021: Vascular Access programme targets impact of high-flow arteriovenous fistulas2021-03-26T14:09:26+00:00

‘Unacceptably high’ major amputation rates and the effects of COVID on the agenda in Hurting Leg session

2021-03-25T09:33:07+00:00

William Jeffcoate (UK) discusses his upcoming presentation at the Hurting Leg session at CX 2021, titled The impact of socio-economic and clinical variables on the incidence of major amputation in people with diabetic foot ulcers.

The session, which will take place on Thursday 22 April, will shine a […]

‘Unacceptably high’ major amputation rates and the effects of COVID on the agenda in Hurting Leg session2021-03-25T09:33:07+00:00

World-class Faculty lined up to tackle Superficial Venous & Lymphatic Controversies

2021-03-05T15:24:48+00:00

Lowell Kabnick (USA) talks about what he is looking forward to in the upcoming Venous & Lymphatic Controversies (Superficial) session at CX 2021. He also discusses his own presentation, Is there evidence to justify an aggressive strategy for the ablation of incompetent perforators?. This controversial topic is “important to the […]

World-class Faculty lined up to tackle Superficial Venous & Lymphatic Controversies2021-03-05T15:24:48+00:00

Lively debates will tackle the biggest controversies in Abdominal Aortic session

2021-03-03T14:40:10+00:00

Colin Bicknell (UK) and Michael Jenkins (UK) will go toe-to-toe in a hotly anticipated debate at CX 2021 titled Standard EVAR can be used in most challenging necks. Bicknell will be arguing for the motion and Jenkins–who is current president of the Vascular Society of Great Britain and Ireland (VSGBI)–will be […]

Lively debates will tackle the biggest controversies in Abdominal Aortic session2021-03-03T14:40:10+00:00

Paclitaxel controversy and Podium 1st presentations take centre stage in Peripheral session

2021-03-01T09:35:45+00:00

Andrew Holden (New Zealand; CX Executive Board Member) discusses some of the main features of the upcoming Peripheral Proximal session at CX 2021 as well as his Podium 1st presentation–Five-year meta-analysis including mortality update with FDA-approved RCTs of paclitaxel devices.

You can register for CX 2021 here. […]

Paclitaxel controversy and Podium 1st presentations take centre stage in Peripheral session2021-03-01T09:35:45+00:00

Catch-up on 20 hours of high-quality aortic education in your own time!

2020-10-15T15:10:56+01:00

Re-live the inaugural CX Aortic Vienna with our complimentary on-demand offering, giving you access to the latest in aortic research and debate from world-leading experts.

This exclusive, one-off opportunity allows you to access every session from CX Aortic Vienna 2020, including the presentations, discussion, audience participation and polling.

CX Aortic Vienna broadcast […]

Catch-up on 20 hours of high-quality aortic education in your own time!2020-10-15T15:10:56+01:00

CX Aortic Vienna 2020: Where content is king

2020-09-03T10:10:18+01:00

Roberto Chiesa (Milan, Italy) talks about the importance of his practical HOW TO DO IT (HDTI) approach, the philosophy of which he will bring to the inaugural CX Aortic Vienna and will manifest through a range of “practical videos” showing the “most modern […]
CX Aortic Vienna 2020: Where content is king2020-09-03T10:10:18+01:00

CX Aortic Vienna 2020: Less than two weeks to go

2020-09-03T09:44:47+01:00

Alexander Zimmermann (Zürich, Switzerland) and Afshin Assadian (Vienna, Austria) talk about the “long tradition of cooperation” between the Austrian Society for Vascular Surgery (ÖGG) and the Swiss Society for Vascular Surgery (SGG), who will hold two joint sessions at the inaugural CX Aortic Vienna.

Zimmermann believes it is a […]

CX Aortic Vienna 2020: Less than two weeks to go2020-09-03T09:44:47+01:00

High quality education on aortic disease treatment at CX Aortic Vienna

2020-09-03T09:35:01+01:00

Maarit Venermo (Helsinki, Finland) talks about how CX Aortic Vienna will offer “high quality education” to people treating aortic diseases, and discusses her presentation at this inaugural event, titled ‘Ultrasound surveillance versus CT surveillance after EVAR’.

CX Aortic Vienna, which will be livestreamed on 8, 9, 10 and 11 September […]

High quality education on aortic disease treatment at CX Aortic Vienna2020-09-03T09:35:01+01:00

CX Aortic Vienna 2020 receives accreditation for 12 EU/US reciprocal CME credits

2020-09-02T14:25:30+01:00

The inaugural CX Aortic Vienna, to be livestreamed on 8, 9, 10 and 11 September 2020 with audience participation, discussion and polling, has been accredited with 12 EU/US reciprocal CME credits.

Accreditation Statement

The CX Aortic Vienna 2020, London (live streaming), United Kingdom, 08/09/2020-11/09/2020 has been accredited […]

CX Aortic Vienna 2020 receives accreditation for 12 EU/US reciprocal CME credits2020-09-02T14:25:30+01:00

CX 2020 LIVE: Surgeon-modified and custom-made endografts carve their place in juxtarenal aneurysm treatment

2020-06-26T17:23:41+01:00

Clockwise from top left: Roger Greenhalgh (London, UK), Stéphan Haulon (Paris, France), Gustavo Oderich (Rochester, USA), Nikolaos Tsilimparis (Munich, Germany), Bijan Modarai (London, UK) and Said Abisi (London, UK). Click on the image to watch the Juxtarenal Aneursym Consesus session on demand.

During […]

CX 2020 LIVE: Surgeon-modified and custom-made endografts carve their place in juxtarenal aneurysm treatment2020-06-26T17:23:41+01:00

Aorta to take centrestage and “starring role” at CX Aortic Vienna

2020-07-16T21:45:19+01:00

Roberto Chiesa (Milan, Italy) invites you to the inaugural CX Aortic Vienna Virtual Conference (8–11 September). The conference will focus on cardiovascular aortic advances and classical open and endovascular solutions. The aorta, notes Chiesa, will play the “starring role” at the conference, where open, endovascular and hybrid techniques will be presented along with other “top-level scientific […]
Aorta to take centrestage and “starring role” at CX Aortic Vienna2020-07-16T21:45:19+01:00

CX 2020 LIVE audience delivers resounding vote in favour of fibre optic visualisation

2020-06-19T17:38:09+01:00

Clockwise from top left: Roger Greenhalgh (London, UK), Gustavo Oderich (Rochester, USA), Roberto Chiesa (Milan, Italy), Eric Verhoeven (Nuremberg, Germany), Frank Arko (Charlotte, USA), and Tilo Kölbel (Hamburg, Germany). Click on the image to watch the Aortic Podium 1st Session on demand.

CX 2020 LIVE audience delivers resounding vote in favour of fibre optic visualisation2020-06-19T17:38:09+01:00

CX 2020 LIVE: Podium 1st Session to showcase new technologies and treatments in abdominal and thoracic aorta

2020-06-17T17:56:25+01:00

Roberto Chiesa (Milan, Italy) invites you to the CX 2020 LIVE Aortic Podium 1st Session which will feature abdominal aortic and thoracic aortic presentations and discussion from specialists in the field, including Tilo Kölbel, Frank Arko, Eric Verhoeven, Stephan Haulon, Giovanni Torsello and Fabio Verzini.

The session, which begins on […]

CX 2020 LIVE: Podium 1st Session to showcase new technologies and treatments in abdominal and thoracic aorta2020-06-17T17:56:25+01:00

CX 2020 LIVE: Vascular Access session showcases new technologies, while debate on place of endovascular fistula creation continues

2020-06-12T16:53:54+01:00

CX 2020 LIVE vascular access panel CX 2020 LIVE’s Vascular Access Consensus panel, including (clockwise from top left): Roger Greenhalgh (London, UK), Nick Inston (Birmingham, UK), Domenico Valenti (London, UK), Robert Jones (Birmingham, UK), Robert Shahverdyan (Hamburg, Germany) and Jennifer Hanko (Belfast, UK). Click […]

CX 2020 LIVE: Vascular Access session showcases new technologies, while debate on place of endovascular fistula creation continues2020-06-12T16:53:54+01:00

CX 2020 LIVE: Deep venous session to examine stent durability and design

2020-06-11T13:20:21+01:00

Armando Mansilha (Porto, Portugal), who is also a member of the CX Venous Executive Board, welcomes you to the Deep Venous Disease Consensus session at CX 2020 LIVE. Deep venous disease is a “significant medical problem for patients” and also a “substantial burden for our healthcare systems”, notes Mansilha.

In […]

CX 2020 LIVE: Deep venous session to examine stent durability and design2020-06-11T13:20:21+01:00

CX 2020 LIVE panel considers advances in thoracic care with new developments in TEVAR

2020-06-05T15:07:47+01:00

Ali Azizzadeh (top) chaired the CX 2020 LIVE Industry Symposium, which featured contributions from Hence Verghagen (bottom row left), Richard Gibbs (bottom row left), and Santi Trimarchi (bottom row right)

Benefits of using angulation control in thoracic endovascular aortic repair (TEVAR), an update […]

CX 2020 LIVE panel considers advances in thoracic care with new developments in TEVAR2020-06-05T15:07:47+01:00

CX 2020 LIVE features key registry data on EVAR durability with EXCLUDER Conformable AAA Endoprosthesis

2020-06-02T09:27:26+01:00

Data from three global, real-world registries, GREAT, ExCeL and BSET-CLEVAR, evaluating the Excluder Conformable abdominal aortic aneurysm (AAA) Endoprosthesis with Active Control System, were shared online during the CX 2020 LIVE virtual, vascular conference. Broadcast to a global audience at the conclusion of the second […]

CX 2020 LIVE features key registry data on EVAR durability with EXCLUDER Conformable AAA Endoprosthesis2020-06-02T09:27:26+01:00

CX 2020 LIVE: Vascular Access education and innovation “imperative” during COVID-19 crisis

2020-05-22T16:58:23+01:00


CX 2020 LIVE will consist of 10 live sessions, which will feature audience participation, and run from 16:00 BST/11:00 EDT/17:00 CEST every Tuesday and Thursday, from 26 May until 25 June. Make sure you register now to participate in the CX 2020 LIVE sessions.

Nicholas Inston (Birmingham, UK), co-chair of the Vascular […]

CX 2020 LIVE: Vascular Access education and innovation “imperative” during COVID-19 crisis2020-05-22T16:58:23+01:00

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes

2020-05-20T12:57:01+01:00

Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes.

A number of recently released “important guidelines” in the superficial venous space will be presented […]

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes2020-05-20T12:57:01+01:00

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session

2020-05-18T18:09:13+01:00

World-leading vascular surgeon, Stéphan Haulon (Paris, France), who is also a member of the CX Aortic Executive Board, extols the “high-quality” digital educational programme of CX 2020 LIVE and highlights the “very exciting” thoracic aortic and abdominal aortic consensus sessions that will be chaired by a host of other experts […]

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session2020-05-18T18:09:13+01:00

COVID-19: No evidence of increased aortic emergencies in Lombardy

2020-05-19T10:33:36+01:00

Roberto Chiesa (Milan, Italy), who was at the frontline of the COVID-19 pandemic in the Lombardy region of Italy, shares his team’s experience in tackling vascular and aortic emergencies during this time.

Chiesa outlines the response in the region to the pandemic, including the creation of new intensive care units (ICUs) […]

COVID-19: No evidence of increased aortic emergencies in Lombardy2020-05-19T10:33:36+01:00

Paclitaxel controversy to headline inaugural CX 2020 LIVE session

2020-07-09T23:32:08+01:00


Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.

Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the […]

Paclitaxel controversy to headline inaugural CX 2020 LIVE session2020-07-09T23:32:08+01:00

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event

2020-05-13T17:13:26+01:00

The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE. Mark your calendars for this live digital experience, designed to deliver high-quality vascular education and featuring […]

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event2020-05-13T17:13:26+01:00

Number of vascular surgeons being trained is “woefully inadequate”

2020-03-09T14:43:42+00:00

Sophie Renton (London, UK) moderates a session with Michel Makaroun (Pittsburgh, USA) and Armando Mansilha (Porto, Portugal) where the trio discuss some of the challenges relating to recruitment within the field of vascular surgery.

Makaroun explains that there are two main recruitment pathways into vascular surgery in the USA but notes […]

Number of vascular surgeons being trained is “woefully inadequate”2020-03-09T14:43:42+00:00

CX 2020: What to expect from this year’s Aortic Workshop

2020-03-09T10:48:40+00:00

Kevin Mani (Uppsala, Sweden) chats to BLearning about the upcoming Aortic Workshop at CX 2020 (Charing Cross Symposium; 21–24 April, London, UK), noting how the sessions will give attendees access to experts, the latest technologies and provide a platform for hands-on experience with new devices and imaging technology.

Workshop participants can take this […]

CX 2020: What to expect from this year’s Aortic Workshop2020-03-09T10:48:40+00:00

Michel Makaroun discusses why the CX Symposium is a “special meeting”

2020-03-09T09:09:07+00:00

Roger Greenhalgh (London, UK) speaks to former president of the SVS (2018–2019) Michel Makaroun (Pittsburgh, USA) about the CX Symposium which Makaroun says “always has a special flavour” and is “a special meeting”. Makaroun also touches on some of the similarities and differences between CX and the SVS meeting in […]

Michel Makaroun discusses why the CX Symposium is a “special meeting”2020-03-09T09:09:07+00:00

Long-term partnership helps drive CX Symposium forward

2020-03-06T09:50:48+00:00

Roger Greenhalgh (London, UK) and W L Gore’s Michael Koenke (Flagstaff, USA), take a look back at the history of the Charing Cross Symposium (CX), which began in 1978.

Koenke says that CX is a “special meeting for us”, adding that it is an “opportunity for us to connect with our […]

Long-term partnership helps drive CX Symposium forward2020-03-06T09:50:48+00:00

Scientific level of CX Symposium “very attractive” for attendees

2020-03-06T09:55:51+00:00

Roger Greenhalgh (London, UK) chats with Enrico Ascher (New York, USA) about some of the highlights of the CX Symposium, how it differs to the VEITH symposium in the USA and also how the two complement each other.

Ascher says he is always “totally amazed by the scientific level” of CX, […]

Scientific level of CX Symposium “very attractive” for attendees2020-03-06T09:55:51+00:00

CX 2019: A Latin American perspective in vascular and endovascular surgery

2020-03-02T14:30:44+00:00

Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery.

Muñoz goes on to highlight the international flavour of Charing Cross and notes the importance of the […]

CX 2019: A Latin American perspective in vascular and endovascular surgery2020-03-02T14:30:44+00:00

CX 2019: Experts discuss latest findings from the STEP study

2019-11-01T10:14:03+00:00

Roger Greenhalgh (London, UK) is joined by Fiona Rohlffs (Hamburg, Germany), Tilo Kölbel (Hamburg, Germany) and Heinz Jakob (Essen, Germany) to discuss the latest findings of the Stroke from Thoracic Endovascular Procedures (STEP) study which were presented at CX 2019 (Charing Cross Symposium; 15–18 April 2019, London, UK). […]

CX 2019: Experts discuss latest findings from the STEP study2019-11-01T10:14:03+00:00

Type II endoleak with secondary sac expansion remains elusive

2020-01-08T13:00:32+00:00

Leading experts including Robert Morgan (London, UK), Richard McWilliams (Liverpool, UK), Stéphan Haulon (Paris, France), Tilo Kölbel (Hamburg, Germany) and Peter Schneider (Honolulu, USA) discuss the various approaches to correcting endoleak during CX 2018 (Charing Cross Symposium; 24–27 April 2018; London, UK).

Type II endoleak with secondary sac expansion remains elusive2020-01-08T13:00:32+00:00

MDR will be “the most devastating thing to happen to European healthcare since WW2”

2019-09-16T10:41:45+01:00

Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare in Europe since World War Two”.

Patients “will bear the brunt of this hardship” says Jump, who […]

MDR will be “the most devastating thing to happen to European healthcare since WW2”2019-09-16T10:41:45+01:00

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

2019-09-06T16:03:07+01:00

Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the […]

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy2019-09-06T16:03:07+01:00

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures

2019-09-06T16:05:44+01:00

Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.

Hayes talks about the accuracy of the device’s deployment around the thoracic […]

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures2019-09-06T16:05:44+01:00

With focal dissection repair, the Tack Endovascular System “returns control to the operator”

2019-09-06T16:08:00+01:00

Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about the “limitations of the current clunky stenting paradigm” and how the […]

With focal dissection repair, the Tack Endovascular System “returns control to the operator”2019-09-06T16:08:00+01:00

Durability of endovascular aneurysm repair and the NICE guidelines

2019-09-06T16:08:53+01:00

A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication of these guidelines has been postponed on numerous occasions.

Opening the session, Stéphan Haulon and his team […]

Durability of endovascular aneurysm repair and the NICE guidelines2019-09-06T16:08:53+01:00

Optimising surveillance and reintervention strategy following elective EVAR

2019-09-06T16:09:48+01:00

Roger Greenhalgh (London, UK) interviewed Fiona Rohlffs (Hamburg, Germany), Maarit Venermo (Helsinki, Finland) and David Epstein (Granada, Spain) at the CX Live studio after their ‘Optimising surveillance and reintervention strategy following elective EVAR’ session.

Optimising surveillance and reintervention strategy following elective EVAR2019-09-06T16:09:48+01:00

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone

2019-09-06T16:10:43+01:00

Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone2019-09-06T16:10:43+01:00

TEVAR performed outside the IFU has “dramatically worse outcomes”

2019-09-06T16:11:31+01:00

Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]

TEVAR performed outside the IFU has “dramatically worse outcomes”2019-09-06T16:11:31+01:00

CX 2019: Highlights from the inaugural iWounds Workshop

2019-09-06T16:16:14+01:00

Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.

Edmonds discusses why “too many legs are being lost” and Serena talks […]

CX 2019: Highlights from the inaugural iWounds Workshop2019-09-06T16:16:14+01:00

Don’t miss: The influence of hyperglycaemia on spinal cord injury

2019-09-06T16:21:31+01:00

Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”

Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]

Don’t miss: The influence of hyperglycaemia on spinal cord injury2019-09-06T16:21:31+01:00

CX 2019: Why a signed consent form “is not consent”

2019-09-06T16:22:57+01:00

Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for informed consent has changed “dramatically” in recent years which has led to “the death of […]

CX 2019: Why a signed consent form “is not consent”2019-09-06T16:22:57+01:00

News from CX 2019: Evidence supports safety of paclitaxel-coated devices

2019-09-06T16:23:55+01:00

At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in the treatment of peripheral arterial disease patients; examines new evidence on […]

News from CX 2019: Evidence supports safety of paclitaxel-coated devices2019-09-06T16:23:55+01:00

Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data

2019-09-06T16:27:30+01:00

There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.

Cook Medical has just announced the release of de-identifiable […]

Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data2019-09-06T16:27:30+01:00

Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word

2019-09-06T16:28:17+01:00

Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.

Ladich believes that “we need to take a step […]

Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word2019-09-06T16:28:17+01:00

CX 2019: Stroke following cardiac surgery is a “wake-up call”; safety of carotid stenting debate

2019-09-06T16:33:28+01:00

In the Acute Stroke Challenges session on Monday, Nick Hopkins talks to CX Live about the “significant increase” of incidents of stroke following cardiac surgery which is “much more common than previously thought”.

Ross Naylor and Peter Schneider debated the impact of new technologies and innovations making carotid artery stenting as […]

CX 2019: Stroke following cardiac surgery is a “wake-up call”; safety of carotid stenting debate2019-09-06T16:33:28+01:00
Go to Top